161 related articles for article (PubMed ID: 11278111)
21. Neuroprotection by estrogen against MPP+-induced dopamine neuron death is mediated by ERalpha in primary cultures of mouse mesencephalon.
Bains M; Cousins JC; Roberts JL
Exp Neurol; 2007 Apr; 204(2):767-76. PubMed ID: 17320868
[TBL] [Abstract][Full Text] [Related]
22. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
[TBL] [Abstract][Full Text] [Related]
23. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
24. Puerarin suppression of Aβ
Li L; Xue Z; Chen L; Chen X; Wang H; Wang X
Brain Res; 2017 Feb; 1657():87-94. PubMed ID: 27923632
[TBL] [Abstract][Full Text] [Related]
25. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
26. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
27. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
Paech K; Webb P; Kuiper GG; Nilsson S; Gustafsson J; Kushner PJ; Scanlan TS
Science; 1997 Sep; 277(5331):1508-10. PubMed ID: 9278514
[TBL] [Abstract][Full Text] [Related]
28. Estrogen-induced changes in the microtubular system correlate with a decreased susceptibility of aging neurons to beta amyloid neurotoxicity.
Shah RD; Anderson KL; Rapoport M; Ferreira A
Mol Cell Neurosci; 2003 Oct; 24(2):503-16. PubMed ID: 14572470
[TBL] [Abstract][Full Text] [Related]
29. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
Mueller SO; Katzenellenbogen JA; Korach KS
Steroids; 2004 Sep; 69(10):681-6. PubMed ID: 15465114
[TBL] [Abstract][Full Text] [Related]
30. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
Hall JM; McDonnell DP
Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
32. Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursor protein in PC12 through a receptor-dependent pathway.
Chae HS; Bach JH; Lee MW; Kim HS; Kim YS; Kim KY; Choo KY; Choi SH; Park CH; Lee SH; Suh YH; Kim SS; Lee WB
J Neurosci Res; 2001 Sep; 65(5):403-7. PubMed ID: 11536323
[TBL] [Abstract][Full Text] [Related]
33. Estrogen provides neuroprotection against activated microglia-induced dopaminergic neuronal injury through both estrogen receptor-alpha and estrogen receptor-beta in microglia.
Liu X; Fan XL; Zhao Y; Luo GR; Li XP; Li R; Le WD
J Neurosci Res; 2005 Sep; 81(5):653-65. PubMed ID: 16013043
[TBL] [Abstract][Full Text] [Related]
34. Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death.
Hosoda T; Nakajima H; Honjo H
Neuroreport; 2001 Jul; 12(9):1965-70. PubMed ID: 11435931
[TBL] [Abstract][Full Text] [Related]
35. Estrogen directly respresses gonadotropin-releasing hormone (GnRH) gene expression in estrogen receptor-alpha (ERalpha)- and ERbeta-expressing GT1-7 GnRH neurons.
Roy D; Angelini NL; Belsham DD
Endocrinology; 1999 Nov; 140(11):5045-53. PubMed ID: 10537130
[TBL] [Abstract][Full Text] [Related]
36. Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway.
Wu J; Pan Z; Wang Z; Zhu W; Shen Y; Cui R; Lin J; Yu H; Wang Q; Qian J; Yu Y; Zhu D; Lou Y
Neuropharmacology; 2012 Sep; 63(3):349-61. PubMed ID: 22534050
[TBL] [Abstract][Full Text] [Related]
37. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
38. Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes.
Inoue H; Shimizu I; Lu G; Itonaga M; Cui X; Okamura Y; Shono M; Honda H; Inoue S; Muramatsu M; Ito S
Dig Dis Sci; 2003 Mar; 48(3):570-80. PubMed ID: 12757172
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
40. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
Zhao L; O'Neill K; Brinton RD
J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
